GW&K Investment Management, LLC - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$82,582
-17.9%
1,663,270
-1.5%
0.83%
-13.0%
Q2 2023$100,570
+4.4%
1,689,122
-0.6%
0.95%
+2.4%
Q1 2023$96,293
-24.3%
1,700,095
-0.7%
0.93%
-27.7%
Q4 2022$127,161
-99.9%
1,712,151
+8.6%
1.29%
+24.4%
Q3 2022$93,895,000
+9.7%
1,576,216
+3.4%
1.04%
+12.2%
Q2 2022$85,567,000
-24.4%
1,524,175
-0.7%
0.92%
-8.5%
Q1 2022$113,208,000
+3.6%
1,534,405
+1.4%
1.01%
+10.5%
Q4 2021$109,230,000
-4.2%
1,512,880
+1.6%
0.91%
-10.4%
Q3 2021$114,068,000
-2.0%
1,488,750
-0.9%
1.02%
+0.6%
Q2 2021$116,433,000
+26.8%
1,501,789
+0.8%
1.01%
+19.7%
Q1 2021$91,855,000
-0.8%
1,489,462
+4.9%
0.85%
-13.0%
Q4 2020$92,636,000
+37.8%
1,420,364
+4.7%
0.97%
+10.5%
Q3 2020$67,202,000
+43.2%
1,357,079
+38.0%
0.88%
+33.5%
Q2 2020$46,926,000
+2.3%
983,578
-8.8%
0.66%
-18.4%
Q1 2020$45,886,000
-44.6%
1,078,911
-23.3%
0.81%
-26.9%
Q4 2019$82,823,000
+12.0%
1,406,651
-2.8%
1.11%
+6.3%
Q3 2019$73,977,000
+63.6%
1,447,134
+35.4%
1.04%
+51.6%
Q2 2019$45,215,000
-16.1%
1,068,923
-2.0%
0.69%
-21.0%
Q1 2019$53,891,000
+9.0%
1,090,699
-4.5%
0.87%
-11.0%
Q4 2018$49,427,000
-26.8%
1,142,034
-4.0%
0.98%
-10.2%
Q3 2018$67,542,000
+11.9%
1,189,952
-0.5%
1.09%
+9.9%
Q2 2018$60,367,000
+0.6%
1,196,329
-0.7%
0.99%
-2.5%
Q1 2018$60,009,000
+13.2%
1,204,509
-6.6%
1.01%
+11.8%
Q4 2017$53,020,000
+24.0%
1,290,034
-10.3%
0.91%
+27.1%
Q3 2017$42,750,000
-10.6%
1,438,428
-0.3%
0.71%
-13.7%
Q2 2017$47,843,000
+8.6%
1,443,222
-3.0%
0.83%
-0.5%
Q1 2017$44,067,000
+19.1%
1,487,753
-0.3%
0.83%
+15.3%
Q4 2016$37,004,000
-4.7%
1,491,496
-13.3%
0.72%
-1.2%
Q3 2016$38,833,000
-6.4%
1,720,549
-1.2%
0.73%
-14.9%
Q2 2016$41,506,000
+10.1%
1,741,751
+9.7%
0.86%
+2.6%
Q1 2016$37,693,000
-11.8%
1,587,055
+3.3%
0.84%
-16.7%
Q4 2015$42,723,000
+31.1%
1,535,697
-2.7%
1.00%
+28.9%
Q3 2015$32,596,000
-18.0%
1,577,749
+1.9%
0.78%
-14.0%
Q2 2015$39,764,000
-0.9%
1,549,060
-2.5%
0.90%
-0.8%
Q1 2015$40,105,000
+4.7%
1,588,949
-1.4%
0.91%
-0.4%
Q4 2014$38,322,000
+21.3%
1,612,188
+0.4%
0.92%
+10.5%
Q3 2014$31,592,000
+1.9%
1,606,121
+23.9%
0.83%
+5.6%
Q2 2014$31,017,000
+45.9%
1,296,677
+62.2%
0.78%
+37.7%
Q1 2014$21,261,000799,5900.57%
Other shareholders
GLOBUS MED INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders